A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mLOngoingOpen NCT05739383 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Loading…